Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Datamonitors' Biocompatibles International plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Biocompatibles International plc since January 2007.
– Provides intelligence on Biocompatibles International plc's M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by Biocompatibles International plc and its subsidiaries since 2007. – Information about key financial and legal advisors for Biocompatibles International plc's financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
This report includes Biocompatibles International plc's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Biocompatibles International plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about Biocompatibles International plc’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
Global Hospital Care Partnering 2014 to 2020 provides the full collection of Hospital Care disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Hospital Care partnering deals Financial deal terms for headline, upfront and royalty by stage of development Hospital...
225 pages •
By Asia Market Information & Development Company
• May 2020
China’s demand for HIV Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
422 pages •
By The Business Research Company
• May 2020
Ophthalmology Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery report provides the strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs market as it emerges from the COVID 19 shut down. Description: Where...
Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H1, 2020 Summary This clinical trial report, “Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H1, 2020" provides an overview of Allergic Rhino-Conjunctivitis Clinical trials scenario.This report provides top line data relating...
The pharmaceutical drug delivery market was valued at US$ 1,403,082.9 million in 2019 and is projected to reach US$ 2,296,170.9 million by 2027; it is expected to grow at a CAGR of 6.6% from 2020 to 2027. Factors driving the pharmaceutical drug delivery market include the growing prevalence of infectious and chronic diseases, and rising R&D...
With the Purchase of Global Central Intravenous Catheter Market Report, Receive a FREE Copy of Market Impact of COVID-19 on Businesses. The central intravenous catheters market is expected to grow at a CAGR of over 5% during the period 2019–2025. The growing prevalence of chronic disorders and the increasing hospital-acquired...
The antibiotics was valued at US$ 43,348.38 million in 2019 and is projected to reach US$ 56,351.33 million by 2027; it is expected to grow at a CAGR of 3.6% from 2020 to 2027. The growing prevalence of bacterial infection is one of the major factors increasing the demand for antibiotics globally. However, expensive process of antibiotic...